This site is intended only for healthcare professionals resident in India

Search

Menu

Close

Sign InLog Out
Our medicinesTherapy areasExplore ContentExplore content

  

MaterialsVideos
Let's connectLet's ConnectPfizer medical information
Novel Therapieshemophilia_logo.pngNovel TherapiesEventshemophilia_logo.pngAboutAboutWhat is Hemophilia?Hemophilia Burden of DiseaseHeritageDiagnosisDiagnosisSigns and SymptomsInvestigationsTreatmentTreatmentTreatment OptionsNovel TherapiesSupport & ResourcesSupport & ResourcesPatient Support ResourcesHemMobile®Patient Support LeafletsEvents

Heritage

Pfizer is committed to supporting people with hemophilia and to improving the long-term outcomes of their condition.

   

Evolution of Science and Innovation in Hemophilia: Pfizer’s Journey So Far

   

Pfizer continues to invest in the research and development of hemophilia treatment. View our Pfizer timeline of milestones in hemophilia, spanning from the early 1990s.

   

Example

The projects mentioned above are for information only and may be available in India.

      

*Now known as Investigator Sponsored Research: https://www.pfizer.com/about/programs-policies/grants/investigator-sponsored-research [Accessed April 27, 2022].

StatConsult is the legal manufacturer of Haemoassist® 2 and Pfizer holds sole distribution rights. Haemoassist® 2 is a CE-marked medical device in Europe, and is currently only available in Germany, Spain, Austria and Portugal, with more launches to come. Haemoassist® 2 is not intended for curing, treating, seeking treatment for, managing or diagnosing a specific disease or disorder, or any specific health condition. Pfizer will not have access to any personal information entered into Hemoassist® 2.

HemMobile® app is only available in certain markets. Restrictions may apply.

§HemMobile® Striiv™ Wearable is currently available in the United States and Argentina. HemMobile® is not intended for curing, treating, seeking treatment for, managing or diagnosing a specific disease or disorder, or any specific health condition.

ǁǁHEMOCRAFT™ is a trademark of Pfizer, Inc. Minecraft is a trademark of Mojang Synergies AB.
HEMOCRAFT™ is provided for educational purposes only and is not intended to replace discussions with a healthcare provider, nor is it intended for curing, treating, seeking treatment for, managing or diagnosing a specific disease or disorder or any specific health condition. HEMOCRAFT™ is currently available in the USA, Sweden and Italy.

Ultrasound imaging is not currently considered standard of care for the assessment of hemophilia in the
United Kingdom and other parts of the world. To find out whether you can access the Pfizer Ultrasound
Programme in your country, please speak to your local country Pfizer representative.

**My Hemophilia Centre app was part of a pilot programme in collaboration with The Royal London Hospital,
UK. The app is now being made more widely available in the United Kingdom, subject to local restrictions. My Hemophilia Centre app is provided for educational purposes only and is not intended for curing, treating, seeking treatment for, managing or diagnosing a specific disease or any specific health condition.

ASPIRE, Advancing Science and Patient care through Innovative Research and Education; ATDC, ataxia-telangiectasia group D-complementing; COVID-19, coronavirus disease 2019; FDA, Food and Drug Administration; HEAD-US, Hemophilia Early Arthropathy Detection with Ultrasound; HIV, human immunodeficiency virus; INSPIIRE, Integrated System for Pfizer Investigator-Initiated Research; NASA, National Aeronautics and Space Administration; SCID, severe combined immunodeficiency; WFH, World Federation of Hemophilia.

References:

Wyeth assumes Europe rights for BeneFIX for hemophilia B. Pharmatimes. Accessed April 27, 2022. www.pharmatimes.com/news/wyeth_assumes_europe_rights_for_benefix_for_haemophilia_b_990302Kelley B, Jankowski M, Booth J. An improved manufacturing process for Xyntha/ReFacto AF. Hemophilia. 2010;16(5):717-725.The World Federation of Hemophilia Twinning Program. Pfizer. Accessed April 27, 2022 https://www.pfizer.com/science/hot- topics/hemophilia-twinning-program‘‘Bubble kid' success puts gene therapy back on track. New Scientist . Accessed April 27, 2022. www.newscientist.com/article/mg22029413-200-bubble-kid-success-puts-gene-therapy-back-on-track/The world’s first web site. History.com. Accessed April 27, 2022. www.history.com/news/the-worlds-first-web-site2003: The human genome project is declared complete. Cancer Research. Accessed April 27, 2022. https://home.cancerresearch/the-human-genome-project-is-declared-complete/A brief history of Facebook. Guardian News. Accessed April 27, 2022. www.theguardian.com/technology/2007/jul/25/media.newmedia Investigator Sponsored Research. INSPIIRE. Accessed April 27, 2022. https://www.pfizer.com/purpose/independent-grants/investigator-sponsored-research'Big Bang' experiment starts well. BBC News. Accessed April 27, 2022.  http://news.bbc.co.uk/2/hi/science/nature/7604293.stmPfizer completes acquisition of Wyeth. Pfizer. Accessed April 27, 2022. https://www.pfizer.com/news/press-release/press-release-detail/pfizer_completes_acquisition_of_wyethChurch DM, Goodstadt L, Hillier LW, et al. Lineage-specific biology revealed by a finished genome assembly of the mouse. PLoS Biol. 2009;7(5):e1000112.EyeWriter. Time. Accessed April 27, 2022. http://content.time.com/time/specials/packages/article/0%2C28804%2C2029497_2030618_2029822%2C00.htmlPfizer award for IBEC/Vall d’Hebron collaboration on hemophilia. IBEC. Accessed April 27, 2022. https://ibecbarcelona.eu/pfizer-award-for-ibecvall-dhebron-collaboration-on-hemophilia/Martinoli C, Della Casa Alberighi O, Di Minno G, et al. Development and definition of a simplified scanning procedure and scoring method for Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US). Thromb Haemost. 2013;109(6):1170-1179.Particles break light-speed limit. Nature. Accessed April 27, 2022. www.nature.com/news/2011/110922/full/news.2011.554.htmlOPERA experiment reports anomaly in flight time of neutrinos from CERN to Gran Sasso. News release. CERN; September 23, 2011. Accessed April 27, 2022. https://home.cern/news/press-release/cern/opera-experiment-reports-anomaly-flight-time-neutrinos-cern-gran-sassoCuriosity rover's descent to Mars – the story so far. The Guardian. Accessed April 27, 2022. www.theguardian.com/science/2013/jul/28/curiosity-rover-descent-mars-nasa'As close to an HIV cure as we've seen': Breakthrough hailed as the radical treatment works on baby born HIV-positive in Atlanta. The Independent. Accessed April 27, 2022. https://www.independent.co.uk/news/science/close-hiv-cure- we-ve-seen-breakthrough-hailed-radical-treatment-works-baby-born-hiv-positive-atlanta-8518617.htmlUpdated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring. WHO. Accessed April 27, 2022. https://www.who.int/publications/i/item/9789240022232Spark Therapeutics announces gene therapy collaboration in hemophilia B with Pfizer Inc. News release. Cision PR Newswire; December 8, 2014. Accessed April 27, 2022. https://www.prnewswire.com/news-releases/spark-therapeutics-announces-gene-therapy- collaboration-in-hemophilia-b-with-pfizer-inc-300005849.htmlThe Nobel Prize in Physiology or Medicine 2014. News release. The Nobel Prize; October 6, 2014. Accessed April 27, 2022. www.nobelprize.org/nobel_prizes/medicine/laureates/2014/press.htmlEURORDIS Awards 2015 for Excellence in the Field of Rare Diseases. Eurodis.org. Accessed April 27, 2022. https://www.eurordis.org/eurordis-awards-2015-for-excellence-in-the-field-of-rare-diseases/NASA confirms evidence that liquid water flows on today’s Mars. News release. NASA; September 28, 2015. Accessed April 27, 2022. www.nasa.gov/press-release/nasa-confirms-evidence-that-liquid-water-flows-on-today-s-marsPfizer acquires Bamboo Therapeutics to beef up gene therapy arsenal. Reuters. Accessed April 27, 2022. www.reuters.com/article/us-bamboo-m-a-pfizer/pfizer-acquires-bamboo-therapeutics-to-beef-up-gene- therapy-arsenal-idUSKCN10C2H7Juno Overview. NASA. Accessed April 27, 2022. www.nasa.gov/mission_pages/juno/overview/index.htmlSangamo Therapeutics and Pfizer announce collaboration for hemophilia A gene therapy. News release. Cision PR Newswire; Mat 10, 2017. Accessed April 27, 2022. www.prnewswire.com/news-releases/sangamo-therapeutics-and-pfizer-announce- collaboration-for-hemophilia-a-gene-therapy-300455555.htmlSoft robot hugs the heart and helps it beat. Eureka. Accessed April 27, 2022. www.eurekamagazine.co.uk/design-engineering-news/soft-robot-hugs-the-heart-and-helps-it-beat/150508/Mum’s a Neanderthal, dad’s a Denisovan: first discovery of an ancient-human hybrid. Nature News. Accessed April 27, 2022. https://www.nature.com/articles/d41586-018-06004-0Pfizer boosts North Carolina footprint with $100 million expansion. NCBiotch. Accessed April 27, 2022. https://www.ncbiotech.org/news/pfizer-boosts-north-carolina-footprint-100-million-expansionRemoval of gene prevents development of pancreatic cancer in mice. EurekAlert. Accessed April 27, 2022. www.eurekalert.org/pub_releases/2019-05/nlh-rog050119.phpHoshika S, Leal NA, Kim MJ, et al. Hachimoji DNA and RNA: a genetic system with eight building blocks. Science. 2019;363(6429):884-887.WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. WHO. Accessed April 27, 2022. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020Mackenzie JS, Smith DW. COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't [published online ahead of print, 2020 Mar 17]. Microbiol Aust. 2020;MA20013FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine. FDA. Accessed April 27, 2022. https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19Virgin Galactic successfully completes first fully crewed spaceflight. Virgin Galactic. Accessed April 27, 2022. https://www.virgin.com/about-virgin/latest/virgin-galactic-successfully-completes-first-fully-crewed-spaceflightBlue Origin safely launches four commercial astronauts to space and back. Blue Origin. Accessed April 27, 2022. https://www.blueorigin.com/news/first-human-flight-updatesKonkle BA, Coffin D, Pierce GF, et al. World Federation of Hemophilia Gene Therapy Registry. Hemophilia. 2020;26(4):563-564.Overcoming the challenges of COVID-19. World Federation of Hemophilia. Accessed April 27, 2022. https://www1.wfh.org/publications/files/pdf-1958.pdf

   

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory.

PP-BEN-IND-0024  22/7/22

About
Support Your Patients

Pfizer is committed to supporting you and your patients with hemophilia.
Learn more about the patient resources available to support your patients.

Patient support resources


Diagnosis

Refresh your knowledge about the symptoms and diagnosis of hemophilia and understand why early diagnosis and treatment may be important for your patients.

Signs and symptoms


Treatment

Understand the current treatment options and recommendations for patients with hemophilia A and B.
 

Treatment options

PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign in or RegisterSign inRegisterAccountSign Out
 
These pages are not intended for patients or for members of the general public. The web pages contain promotional content. For the use only of Registered Medical Practitioners or a Hospital or a Laboratory. Full prescribing information available on request. For more details on, Who is a Registered Medical Practitioner, please visit "https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf", Page No. 39, Rule 2 part (ee), last accessed on 26th April2021.
​​​​​​​
Address: The Capital,  A Wing, 1802, 18th Floor, Plot No. C-70, ‘G’ Block, Bandra Kurla Complex, Bandra East, Mumbai – 400051, India.
 
PP-BEN-IND-0024

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

ButtonButton

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Hac habitasse platea dictumst quisque sagittis purus sit amet volutpat. Lectus magna fringilla urna porttitor rhoncus. Venenatis urna cursus eget nunc scelerisque viverra. Id donec ultrices tincidunt arcu non sodales.

Sagittis aliquam malesuada bibendum arcu vitae elementum curabitur. Pellentesque elit ullamcorper dignissim cras tincidunt. Orci ac auctor augue mauris augue neque. Dui vivamus arcu felis bibendum ut tristique et egestas quis. Sed vulputate mi sit amet mauris commodo.

Nunc eget lorem dolor sed viverra ipsum. Sed ullamcorper morbi tincidunt ornare.

 
Copyright © 2022 Pfizer Limited, India. All rights reserved. Applicable for Pfizer Products, Product Microsites and Therapy Areas section of the website:
  • All content published herein is intended and strictly only for informational, educational, academic and/or research purposes and shall not be utilized to diagnose or treat a health problem or disease without referring to the full prescribing information for list of approved indications as contained in the product package insert
  • ​​​​​​​While due care and caution has been taken to ensure that the content herein is free from mistakes or omissions, Pfizer makes no claims, promises or guarantees about the accuracy, completeness or adequacy of the information herein
 
For the use of Registered Medical Practitioners only*

These pages are not intended for patients or for members of the general public. The web pages contain promotional content.


If you select 'No', you will be redirected to Pfizer.co.in

For more details on, Who is a Registered Medical Practitioner*, please visit https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf , Page No. 39, Rule 2 part (ee), last accessed on 13th September 2019.
​​​​​​​Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.


PP-UNP-IND-0012 July 2022
Yes No
You are now leaving PfizerPro website
​​​​​​​ ​
​​​​​You are now leaving Pfizer Pro website and will be redirected to another website. Note that you will be governed by the Terms & Conditions and Privacy Policy of the external website. Would you like to continue?

PP-UNP-IND-0012 July 2022


​​​​​​​